CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (33.33%)
Dec 30, 2025, 9:30 AM EST
CBD Life Sciences Market Cap
CBD Life Sciences has a market cap or net worth of $854.55 thousand as of December 30, 2025. Its market cap has decreased by -28.62% in one year.
Market Cap
854.55K
Enterprise Value
n/a
Revenue
178.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 31, 2012, CBD Life Sciences's market cap has decreased from 36.67M to 854.55K, a decrease of -97.67%. That is a compound annual growth rate of -24.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 854.55K | -43.68% |
| Dec 31, 2024 | 1.52M | 3,469.86% |
| Dec 29, 2023 | 42.51K | 4.42% |
| Dec 30, 2022 | 40.71K | -99.50% |
| Dec 31, 2021 | 8.14M | 62.45% |
| Dec 31, 2020 | 5.01M | 909.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 748.72M |
| Elite Pharmaceuticals | 537.07M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 379.67M |
| CytoDyn | 353.44M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |